LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 2 filers reported holding LOXO ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,078,000 | -75.5% | 7,699 | -70.1% | 0.00% | -66.7% |
| Q3 2018 | $4,406,000 | +278.5% | 25,792 | +284.4% | 0.00% | +200.0% |
| Q2 2018 | $1,164,000 | -83.0% | 6,710 | -88.7% | 0.00% | -80.0% |
| Q1 2018 | $6,844,000 | +1311.1% | 59,327 | +927.7% | 0.01% | – |
| Q4 2017 | $485,000 | +97.2% | 5,773 | +116.6% | 0.00% | – |
| Q3 2017 | $246,000 | +100.0% | 2,665 | +72.9% | 0.00% | – |
| Q2 2017 | $123,000 | -40.6% | 1,541 | -68.6% | 0.00% | – |
| Q1 2017 | $207,000 | +43.8% | 4,913 | +9.6% | 0.00% | – |
| Q4 2016 | $144,000 | +89.5% | 4,484 | +54.9% | 0.00% | – |
| Q3 2016 | $76,000 | +22.6% | 2,894 | +8.6% | 0.00% | – |
| Q2 2016 | $62,000 | +6100.0% | 2,664 | +6560.0% | 0.00% | – |
| Q3 2015 | $1,000 | -66.7% | 40 | -73.3% | 0.00% | – |
| Q2 2015 | $3,000 | +200.0% | 150 | +33.9% | 0.00% | – |
| Q1 2015 | $1,000 | -50.0% | 112 | -45.6% | 0.00% | – |
| Q4 2014 | $2,000 | – | 206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,438,920 | $289,488,000 | 57.19% |
| DAFNA Capital Management LLC | 296,000 | $24,917,000 | 13.42% |
| Casdin Capital, LLC | 360,000 | $30,305,000 | 7.38% |
| Opaleye Management Inc. | 176,300 | $14,841,000 | 4.75% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 574,495 | $48,361,000 | 1.84% |
| SECTORAL ASSET MANAGEMENT INC | 152,185 | $12,811,000 | 1.60% |
| AWM Investment Company, Inc. | 85,000 | $7,155,000 | 1.39% |
| Eventide Asset Management | 285,000 | $23,991,000 | 1.25% |
| Rock Springs Capital Management LP | 310,000 | $26,096,000 | 1.18% |
| Crawford Lake Capital Management, LLC | 53,420 | $4,497,000 | 1.06% |